Frequently Asked Questions

What are the different pharma consulting services?

 

Our pharma consulting services cover a wide range of critical areas, including end-to-end commercialisation strategies, governance frameworks, market acceleration, and launch optimisation. We also provide portfolio prioritisation, corporate strategy development, and investor readiness coaching.

 

At iWisdom, we take a hands-on approach to helping clients achieve sustainable growth by bridging the gap between clinical research, commercial functions, and consumer insights. Our services are designed to eliminate silos, maximise asset value, and support successful pharmaceutical ventures.

 

What should you consider for a new product launch in the pharma industry?

 

When planning a new product launch in the pharma industry, several factors must be considered. These include understanding market dynamics, identifying target patient groups, and building a clear go-to-market strategy. Regulatory approvals and pricing strategies are also crucial.

 

iWisdom works with clients to align R&D, clinical, and commercial teams, ensuring a smooth transition from development to market. Additionally, it's vital to develop a compelling narrative for stakeholders and investors to ensure ongoing support and funding. Careful planning at every stage enhances the chances of a successful launch.

 

How long does a pharma product launch take?

 

The timeline for a pharma product launch can vary, but it typically takes anywhere from 18 months to several years. This depends on the complexity of the product, the regulatory process, and market readiness.

 

At iWisdom, we work to expedite the process by integrating cross-functional teams early, streamlining regulatory submissions, and ensuring market alignment. Our hands-on approach ensures that we hit key milestones quickly, which can significantly reduce time-to-market and increase the likelihood of a successful launch.

 

What are the benefits of pharmaceutical consulting?

 

Pharmaceutical consulting provides numerous benefits, including expert guidance through the complexities of the pharma industry. At iWisdom, we offer tailored advice on product development, regulatory navigation, and market strategies.

 

Our consultants help businesses optimise their portfolios, align clinical and commercial goals, and prepare for funding rounds. With a focus on value creation, our team assists clients in making informed decisions that boost growth and profitability. Through our strategic insights, clients can reduce risks and achieve sustainable, long-term success in the competitive pharmaceutical market.

 

What are the steps in the pharmaceutical development process?

 

The pharmaceutical development process involves several critical stages: discovery, preclinical testing, clinical trials, regulatory approval, and commercialisation. Initially, new compounds are discovered and tested in preclinical models, followed by clinical trials in human subjects. Upon successful trials, regulatory submissions are made for approval. Once approved, the product is launched to market.

 

At iWisdom, we guide clients through each stage, ensuring smooth transitions, efficient processes, and market alignment. Our expertise helps clients optimise their development strategy, improving their chances of success in a competitive market.

 

How best to obtain pharmaceutical investment?

 

Securing pharmaceutical investment requires a well-rounded strategy that demonstrates the value of your product and the potential for market success. Key considerations include preparing a strong business case, showcasing clinical trial data, and identifying strategic partnerships.

 

iWisdom helps clients develop compelling investment narratives that attract potential investors. We also provide strategic advice on opportunity screening and preparing for funding rounds. By aligning corporate strategy with investor interests, our team ensures clients are well-positioned to secure the necessary funding to drive their pharmaceutical ventures forward.